GENO Pharmaceutical Technology focuses on the characteristics of the pharmaceutical industry, creating a customized financial service system covering the entire industry chain, and accurately solving the funding pain points in the development of pharmaceutical enterprises.

In response to the challenges of long research and development cycles and large capital investment in innovative drugs, Jingnuo has launched a "milestone financing" service for research and development. Collaborate with professional pharmaceutical evaluation agencies to conduct in-depth analysis of the technical barriers and clinical value of the project, and provide tiered credit to pharmaceutical companies in different stages such as preclinical and phase I-III trials. After pharmaceutical companies reach key research and development milestones, they can quickly obtain follow-up funding support, effectively avoiding "food shortages" in the middle of research and development. Currently, they have helped 12 innovative drug projects advance to the clinical stage.

In the pharmaceutical circulation process, Jingnuo has built a "supply chain finance ecosystem platform". Based on the real trade background, we provide accounts receivable pledge financing for raw material drug suppliers, order loans for production enterprises, and warehouse receipt pledge services for distributors. The platform is integrated into the ERP system of pharmaceutical companies to achieve real-time data exchange, improve loan efficiency by 60%, and help upstream and downstream enterprises in the industry chain shorten the average payment cycle by 30 days.